Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹195.85
3.02 (1.57%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹3.07K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
31.0
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹128.5+52.4%
52W High₹321.95-39.2%
Current Price
₹195.85
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹156.68
Upper Circuit₹235.02
Reference Price
₹195.85
Investment Checklist
Rounding Bottom on 1D — target ₹225.83
Descending Channel on 1W — target ₹189.97
10/20 Bullish Cross detected 5 day(s) ago
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
46%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
185.89
EMA50
183.38
EMA200
210.63
Price Action
UPTREND
BULLISH
Higher Highs6
Higher Lows8
Lower Highs3
Lower Lows1
Support & Resistance Levels
Resistance (Above)
₹200.04
₹211.55
₹224.40
₹228.00
₹233.52
Support (Below)
₹194.85
₹177.58
₹173.80
₹167.48
₹154.47
Volume Analysis
TrendINCREASING
Change+21.00%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bullish Cross
5 days ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹193.89
3% Risk₹189.97
5% Risk₹186.06
7% Risk (Custom)
₹182.14Technical Levels
1x ATR (Volatility)₹187.30
2x ATR (Swing)₹178.75
3x ATR (Trend)₹170.20
Immediate Support₹194.85
Moving Averages
EMA 9 (Short-term)₹190.00
EMA 20 (Medium-term)₹185.89
EMA 50 (Trend)₹183.38
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹682.3 Cr | ₹646.9 Cr | ₹708.1 Cr | ₹719.8 Cr |
| Net Profit | ₹4.6 Cr | ₹43.1 Cr | ₹23.4 Cr | ₹-13 Cr |
| EPS | ₹0.30 | — | ₹1.49 | ₹-0.83 |
| Operating Profit | ₹147.8 Cr | ₹141 Cr | ₹162.8 Cr | ₹119.8 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Dishman Carbogen Amcis Limited | ₹195.85 | +1.57% | 31.0 | ₹3.07K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 12 Sept 2019 | Dividend - Rs 0.20 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for DCAL
View AllNEWS
positive
Business Standard - Markets 11d ago
Dishman Carbogen gains after Swiss unit commissions 1,200 kWp solar facility
Dishman Carbogen Amcis added 2.91% to Rs 173.45 after the company's wholly owned subsidiary namely CARBOGEN AMCIS AG., has successfully commissioned a ground-mounted photovoltaic system at its Neuland site in Switzerland.
DCALSOLARINDSChemicalsHealthcare
NEWS
negative
Business Standard - Markets 49d ago
Suraj Ltd leads losers in 'B' group
SMS Pharmaceuticals Ltd, RSD Finance Ltd, Grand Oak Canyons Distillery Ltd and Dishman Carbogen Amcis Ltd are among the other losers in the BSE's 'B' group today, 22 May 2026.
BSEDCALGRANDOAKLTFRSDFINSMSPHARMASURAJLTDCapital GoodsFinancial Services
NEWS
positive
Business Standard - Markets 52d ago
Dishman Carbogen Amcis consolidated net profit declines 49.55% in the March 2026 quarter
Sales rise 18.85% to Rs 851.40 crore
DCALHealthcare